2014
DOI: 10.1097/lgt.0000000000000018
|View full text |Cite
|
Sign up to set email alerts
|

“Equivocal” High-Risk HPV DNA Tests Performed on ThinPrep Specimens After ASC-US Diagnoses Are Associated With an Increased Incidence of CIN3

Abstract: ASC-US in association with equivocal and positive HC II results respectively shows similar incidences of CIN2/3 on 2-year follow-up cervical biopsy. Additionally, a significant proportion of CIN3 biopsies are in the equivocal HC II cohort. As clinical decision making would be impacted by this finding, laboratories should consider evaluating the clinical performance of their HC II assay via correlation with subsequent cervical biopsies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 28 publications
0
1
0
Order By: Relevance
“…Twenty-four patients (38%) had a diagnosis of atypical glandular cells on their Pap smear before their AIS diagnosis. More than half of the patients (60%, 52 of 87) were known HPV positive, 1 (1%) was known HPV negative, 33 (40%) were HPV unknown, 17 and 1 (1%) was HPV equivocal. The HPV DNA testing started at our institution in 2004 with Hybrid Capture 2, an enzyme immunoassay.…”
Section: Resultsmentioning
confidence: 99%
“…Twenty-four patients (38%) had a diagnosis of atypical glandular cells on their Pap smear before their AIS diagnosis. More than half of the patients (60%, 52 of 87) were known HPV positive, 1 (1%) was known HPV negative, 33 (40%) were HPV unknown, 17 and 1 (1%) was HPV equivocal. The HPV DNA testing started at our institution in 2004 with Hybrid Capture 2, an enzyme immunoassay.…”
Section: Resultsmentioning
confidence: 99%